Compound details
Cibotiumbaroside A
| Compound ID | CDAMM01923 |
|---|---|
| Common name | Cibotiumbaroside A | IUPAC name | [3,4,5-trihydroxy-6-[(5-oxo-2H-furan-4-yl)methoxy]oxan-2-yl]methyl 3,4-dihydroxybenzoate |
| Molecular formula | C18H20O11 |
| Retention time | 14.59 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 413.105 | Theoretical mz | 413.108 |
| Error | 7.93 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.0725 |
| Inchi key | MPWNIHQZXAKHOM-WDTGNJSLNA-N |
|---|---|
| Smiles | O=C(OCC1OC(OCC2=CCOC2=O)C(O)C(O)C1O)C3=CC=C(O)C(O)=C3 |
| Superclass | Organic oxygen compounds |
| Class | Organooxygen compounds |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P05121 | SERPINE1 | Plasminogen activator inhibitor-1 | T15556 | SEA |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| P05230 | FGF1 | Acidic fibroblast growth factor | T18639 | SEA |
| P09038 | FGF2 | Basic fibroblast growth factor | T31621 | SEA |
| P01112 | HRAS | Transforming protein p21/H-Ras-1 | T71081 | SEA |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| Q9NUW8 | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | T33492 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| P11717 | IGF2R | Insulin-like growth factor II receptor | T59550 | SEA |
| Q99417 | MYCBP | MYCBP messenger RNA | T37298 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T15556 | DI0037 | Asthma | [ICD-11: CA23] | P05121 | SERPINE1 |
| T15556 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P05121 | SERPINE1 |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T31621 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P09038 | FGF2 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T59550 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P11717 | IGF2R |
| T59550 | DI0368 | Sarcoidosis | [ICD-11: 4B20] | P11717 | IGF2R |
| T37298 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q99417 | MYCBP |